Characterization of subpopulation lacking both B-cell and plasma cell markers in Waldenstrom macroglobulinemia cell line

Laboratory Investigation

Volumn 94, Issue 1, 2014, Pages 79-88

  Wada, Naoki ^a   Zhan, Maosheng ^a   Hori, Yumiko ^a   Honma, Keiichiro ^a   Ikeda, Jun Ichiro ^a   Morii, Eiichi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

cancer initiating cells; CD138; CD20; lymphoplasmacytic lymphoma; Waldenstrom macroglobulinemia

Indexed keywords

CD20 ANTIBODY; CD20 ANTIGEN; CELL ANTIBODY; CELL MARKER; REACTIVE OXYGEN METABOLITE; SYNDECAN 1; SYNDECAN 1 ANTIBODY; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INITIATING CELL; COLONY FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPHOCYTE SUBPOPULATION; LYMPHOMA CELL LINE; NONHODGKIN LYMPHOMA; PLASMA CELL; PRIORITY JOURNAL; STAINING; WALDENSTROEM MACROGLOBULINEMIA;

ANTIGENS, CD20; APOPTOSIS; B-LYMPHOCYTES; BIOLOGICAL MARKERS; CELL AGING; CELL LINE, TUMOR; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOPHENOTYPING; PHENOTYPE; REACTIVE OXYGEN SPECIES; SYNDECAN-1; WALDENSTROM MACROGLOBULINEMIA;

EID: 84891512631     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2013.129     Document Type: Article

References (27)

1. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997;3:730-737
2. Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-111
3. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003;100:3983-3988
4. Lessard J, Sauvageau G. Bmi-1 determined the proliferative capacity of normal and leukaemic stem cells. Nature 2003;423:255-260
5. Kondo T, Setoguchi T, Taga T. Persistence of a small subppulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA 2004;101:781-786
6. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature 2004;432:396-401
7. O'Brien CA, Pollett A, Gallinger S, et al. A human colon cancer cell capable of initiating tumor growth in immunodeficient mice. Nature 2007;445:106-110
8. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. Identification and expansion of human colon-cancer initiating cells. Nature 2007;445:111-115
9. Ikeda J, Mamat S, Tian T, et al. Tumorigenic potential of mononucleated small cells of Hodgkin lymphoma cell lines. Am J Pathol 2010;177:3081-3088
10. Ikeda J, Mamat S, Tian T, et al. Reactive oxygen species and aldehyde dehydrogenase activity in Hodgkin lymphoma cells. Lab Invest 2012;92:606-614
11. Hamburger AW, Salmon SE. Primary bioassay of human tumor stem cells. Science 1977;197:461-463
12. Diehn M, Cho RW, Lobo NA, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 2009;458:780-783
13. Owen RG, Treon SP, Al-Katib A, et al. Clinicopathological definition of Waldenstrom's macroglobulinemia: Consensus panel recommendations from the Second International Workshop on Waldenstrom's macroglobulinemia. Semin Oncol 2003;30:110-115
14. Swerdlow SH, Berger F, Pileri SA, et al. Lymphoplasmacytic lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al. (eds WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. (, Lyon, 2008) p194-195
15. Barakat FH, Medeiros J, Wei EX, et al. Residual monotypic plasma cells in patients with Waldenstrom macroglobulinemia after therapy. Hematopathology 2011;135:365-373
16. Konoplev S, Medeiros J, Bueso-Ramos CE, et al. Immunophenotypic profile of lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia. Am J Clin Pathol 2005;124:414-420
17. Morice WG, Chen D, Kurtin PJ, et al. Novel immunophenotypic features of marrow lymphoplasmacytic lymphoma and correlation with Waldenstrom's macroglobulinemia. Mod Pathol 2009;22: 807-816
18. Hodge LS, Novak AJ, Grote DM, et al. Establishment and characterization of a novel Waldenstrom macroglobulinemia cell line, MWCL-1. Blood 2011;117:e190-e197
19. Tothova Z, Kollipara R, Huntly BJ, et al. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 2007;128:325-339
20. Miyamoto K, Araki KY, Naka K, et al. FoxO3a is essential for maintenance of hematopoietic stem cell pool. Cell Stem Cell 2007;1:101-112
21. Burgering BM. A brief introduction to FOXOlogy. Oncogene 2008;27:2258-2262
22. Brunet A, Bonni A, Zigmond MJ, et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999;96:857-868
23. Brownawell AM, Kops GJ, Macara IG, et al. Inhibition of nuclear import by protein kinase B (Akt) regulates the subcellular distribution and activity of the forkhead transcription factor AFX. Mol Cell Biol 2001;21:3534-3546
24. Franke A, Niederfellner GJ, Klein C, et al. Antibodies against CD20 or B-cell receptor induce similar transcription patterns in human lymphoma cell lines. PLoS One 2011;6:e16596
25. Limon JJ, Fruman DA. Akt and mTOR in B cell activation and differentiation. Front Immunol 2012;3:1-12
26. Signore M, Ricci-Vitiani L, De Maria R. Targeting apoptosis pathways in cancer stem cells. Cancer Lett 2013;332:374-382
27. Cheng L, Alexander R, Zhang S, et al. The clinical and therapeutic implications of cancer stem cell biology. Expert Rev Anticancer Ther 2011;11:1131-1143.